NOVEMBER 7-8, 2024

Portfolio Events

Mast Cell Tumors Part 2: Treatment Options & Client Communication

07 Nov 2024
Bronx Clinical Theater

Even though veterinarians frequently diagnose mast cell tumors in dogs, there is a great deal of confusion about what treatments result in optimal management of dogs with these tumors. Surgery, chemotherapy and radiation therapy all play a role in the management of canine mast cell tumors. Assessment of prognostic factors such as breed, anatomic location, tumor size, tumor grade (Patnaik and Kiupel systems), completeness of surgical excision, lymph node and distant metastasis, mitotic count and tumor markers determined using immunohistochemistry help direct treatment decisions.

Research has shown owner of pets with cancer expect to be presented with all treatment options available to their pet. Client communication should focus on outlining evidence-based treatment options and explaining the prognosis, treatment protocol and monitoring schedule for each option. Studies also indicate clients want their primary care veterinarian to remain involved in their pet’s medical care.

Attendees will learn:

  • Factors impacting treatment decisions in dogs with mast cell tumors.
  • Optimal use of surgery, chemotherapy and radiation therapy in dogs with mast cell tumors.
  • Communication strategies appropriate to owners of dogs with mast cell tumors.
Ann Elizabeth Hohenhaus, Director, Pet Health Information - Schwarzman Animal Medical Center

Be the leader of your pack

Be the first to hear the latest news, program updates and exclusive industry releases.